Relationship between renal function and heart failure in hypertensive patients

Internal Medicine Journal

Volumn 40, Issue 1, 2010, Pages 76-79

  Luque, M ^a   De Rivas, B ^b   Divison J A ^c   Marquez E ^d   Sobreviela, E ^e  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b ASTRAZENECA   (United Kingdom)

^c Casas Ibáñez Primary Care Center   (Spain)

^d La Orden Primary Care Center   (Spain)

^e IQVIA   (United States)

Author keywords

Heart failure; Hypertension; Renal dysfunction

Indexed keywords

CREATININE;

AGED; ARTICLE; CARDIOMEGALY; CLINICAL FEATURE; CLINICAL TRIAL; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HIGH RISK PATIENT; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SPAIN;

AGED; CROSS-SECTIONAL STUDIES; FEMALE; HEART FAILURE; HUMANS; HYPERTENSION; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE;

EID: 76749105696     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2009.02075.x     Document Type: Article

References (11)

1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003 42 : 1206 1252.
2. -2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. Guidelines Committee. J Hypertens 2003 21 : 1011 1053.
3. Redon J, Cea-Calvo L, Lozano JV, Fernandez-Perez C, Navarro J, Bonet A et al. ERIC-HTA 2003 Study Investigators. Kidney function and cardiovascular disease in the hypertensive population: the ERIC-HTA study. J Hypertens 2006 24 : 663 669.
4. Smilde TD, Hillege HL, Voors AA, Dunselman PH, Van Veldhuisen DJ. Prognostic importance of renal function in patients with early heart failure and mild left ventricular dysfunction. Am J Cardiol 2004 94 : 240 243.
5. Hillege HL, Nitsch D, Pfeffer MA, Swedberg K, McMurray JJ, Yusuf S et al. Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Investigators. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 2006 113 : 671 678.
6. Hillege HL, Girbes AR, de Kam PJ, Boomsma F, de Zeeuw D, Charlesworth A et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 2000 102 : 203 210.
7. Kannel WB, D'Agostino RB, Silbershatz H, Belanger AJ, Wilson PWF, Levy D. Profile for estimating risk of heart failure. Arch Intern Med 1999 159 : 1197 1204.
8. Hallan S, Asberg A, Lindberg M, Johnsen H. Validation of the Modification of Diet in Renal Disease formula for estimating GFR with special emphasis on calibration of the serum creatinine assay. Am J Kidney Dis 2004 44 : 84 93.
9. Herrero P, Marín R, Fernández Vega F, Gorostidi M, Riesgo A, Vázquez J et al. Renal function and cardiovascular risk in patients with essential hypertension. The 'FRESHA' study. Nefrología 2006 26 : 330 338.
10. Schrier RW. Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor? J Am Coll Cardiol 2006 47 : 1 8.
11. Anwaruddin S, Lloyd-Jones DM, Baggish A, Chen A, Krauser D, Tung R Jr. et al. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement results from the ProBNO Investigation of Dyspnea in the Emergency Department (PRIDE) Study. J Am Coll Cardiol 2006 47 : 91 7.